About: Pascal Hammel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pascal Hammel Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) 研究者 (zh) հետազոտող (hy) hulumtues (sq)
rdfs:label	Pascal Hammel (en) Pascal Hammel (es) Pascal Hammel (nl) Pascal Hammel (sl) Pascal Hammel (ast)
skos:prefLabel	Pascal Hammel (en) Pascal Hammel (es) Pascal Hammel (nl) Pascal Hammel (sl) Pascal Hammel (ast)
name	Pascal Hammel (en) Pascal Hammel (es) Pascal Hammel (nl) Pascal Hammel (sl) Pascal Hammel (ast)
given name	wds:Q42932125-6CE1BC8F-1D33-43EA-96AA-DD48BBC8134E
given name	Pascal
instance of	wds:Q42932125-E50DBC43-31B3-422F-A964-18F2E7B8452B
instance of	Homo sapiens
occupation	wds:Q42932125-F3BE05E9-6E78-4B7C-8FB2-6CEF0DD651EA
sex or gender	wds:Q42932125-1549038B-A57F-4384-9FA4-8F9A2C254ADB
date of birth	wds:Q42932125-8DA66176-EA42-461E-B070-728D6413EC96
family name	wds:Q42932125-FC16FB8F-74C7-4AA9-9AE6-C84D760288FB
occupation	researcher
sex or gender	male
date of birth	2000-01-01 00:00:00Z (xsd:dateTime)
family name	Hammel
ORCID iD	wds:Q42932125-0945415B-6BDF-4CCD-AA78-8D4A2B1F273A
ORCID iD	https://orcid.org/0000-0002-4630-4996
ORCID iD	0000-0002-4630-4996
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q42932125
is author of	Sunitinib in pancreatic neuroendocrine tumors. Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas. Risk of pancreatic adenocarcinoma in chronic pancreatitis The natural history of hereditary pancreatitis: a national series Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms: the interest of endoscopic ultrasonography Pathology Analysis Reveals That Dysplastic Pancreatic Ductal Lesions Are Frequent in Patients With Hereditary Pancreatitis Acute pancreatitis revealing Behçet disease Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer Discrimination of unilocular macrocystic serous cystadenoma from pancreatic pseudocyst and mucinous cystadenoma with CT: initial observations Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). Clinical and genetic studies of Birt-Hogg-Dubé syndrome. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. Increased p53 protein content of colorectal tumours correlates with poor survival. Risk factors for diabetes mellitus in chronic pancreatitis Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors Assessment of complications of EUS-guided fine-needle aspiration. Pancreatic metastases: a multicentric study of 22 patients Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma Severe thrombopenia as single sign of hemophagocytosis in a patient with cirrhosis and lethal infection of ascitis fluid by Escherichia coli Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). Gemcitabine in elderly patients with advanced pancreatic cancer Tumeur des cellules épithélioïdes périvasculaires (PECome) du pancréas Recurrent acute pancreatitis caused by association of a novel mutation of the calcium-sensing receptor gene and a heterozygous mutation of the SPINK1 gene Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Pancreatic involvement in von Hippel–Lindau disease Recurrence after surgical resection of gastrinoma: who, when, where and why? Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis Molecular packing and magnetic properties of lithium naphthalocyanine crystals: hollow channels enabling permeability and paramagnetic sensitivity to molecular oxygen. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Clinical and morphological features of duodenal cystic dystrophy in heterotopic pancreas.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software